About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
8th Annual USC Multidisciplinary Breast Cancer Symposium
Videos
8th Annual USC Multidisciplinary Breast Cancer Symposium
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Oncoplastic Surgery and BC: What Is Extreme Oncoplasty? When Can We Use It?
By
8th Annual USC Multidisciplinary Breast Cancer Symposium
FEATURING
Melvin Silverstein
By
8th Annual USC Multidisciplinary Breast Cancer Symposium
FEATURING
Melvin Silverstein
41 views
February 9, 2021
0 Comments
Login to view comments.
Click here to Login
Videos
05:35
8th Annual USC Multidisciplinary Breast Cancer Symposium
HR+HER2- High-Risk eBC: Surveying Efficacy Data of CDK4/6i in the Ad…
Feat.
G. Sledge
09:19
8th Annual USC Multidisciplinary Breast Cancer Symposium
HR+/HER2- MBC: Outcomes of 1/2L CDK4/6 Inhibition
Feat.
G. Sledge
09:50
8th Annual USC Multidisciplinary Breast Cancer Symposium
ER+ Early Stage BC: Which Patients Should Avoid Chemotherapy? Does C…
Feat.
G. Sledge
06:22
8th Annual USC Multidisciplinary Breast Cancer Symposium
PI3K/AKT/mTOR Inhibition in Advanced BC: Is There Any Benefit With A…
Feat.
G. Sledge
30:59
8th Annual USC Multidisciplinary Breast Cancer Symposium
Genetic Risk in BC: BRCA1/2 Mutations, Genetic Testing, Preventive B…
Feat.
B. Arun
35:08
8th Annual USC Multidisciplinary Breast Cancer Symposium
Oncoplastic Surgery and BC: What Is Extreme Oncoplasty? When Can We …
Feat.
M. Silverstein
28:38
8th Annual USC Multidisciplinary Breast Cancer Symposium
Diagnostic MRI for Newly Diagnosed BC: Factors of Occult Lesions Det…
Feat.
S. Sener
39:07
8th Annual USC Multidisciplinary Breast Cancer Symposium
2021 Challenges in HER2+ BC Testing: IHC Guidelines, Biomarker Testi…
Feat.
M. Press
18:27
8th Annual USC Multidisciplinary Breast Cancer Symposium
2021 Updates on HER2+ MBC: What Does the New Data on T-DXd Suggest? …
Feat.
W. Gradishar
11:34
8th Annual USC Multidisciplinary Breast Cancer Symposium
2021 Updates on HER2+ MBC: Tucatinib Combo and HRQoL in Brain Mets, …
Feat.
W. Gradishar
19:06
8th Annual USC Multidisciplinary Breast Cancer Symposium
USC Update on 1L Chemo Combination for Advanced TNBC: Does the Addit…
Feat.
S. Hurvitz
06:31
8th Annual USC Multidisciplinary Breast Cancer Symposium
Innovations in Management of mTNBC: PARP Inhibitors
Feat.
S. Hurvitz
13:11
8th Annual USC Multidisciplinary Breast Cancer Symposium
Clinical Trial Data on ADCs in TNBC: Sacituzumab Govitecan Efficacy …
Feat.
S. Hurvitz